Mayr-Melnhof Karton (MMK) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
28 Apr, 2026Executive summary
Significant year-over-year earnings increase in Q1 2025, mainly driven by the Board & Paper and Food & Premium Packaging divisions, despite continued soft demand and margin pressure; Pharma & Healthcare Packaging lagged due to one-off effects and delayed product rollouts.
The company remains a market leader in fiber-based consumer packaging, focusing on efficiency, innovation, and sustainability, with ongoing cost, technology, and innovation leadership initiatives.
Diversified portfolio across Board & Paper, Food & Premium Packaging, and Pharma & Healthcare Packaging.
Financial highlights
Q1 2025 sales rose 1.7% to €1,042.6 million compared to Q1 2024.
Adjusted EBITDA increased 26.2% to €119.3 million; margin improved by 222 bp to 11.4%.
Adjusted operating profit up 53.7% to €61.0 million; margin at 5.8%.
Net profit nearly doubled to €21.1 million; EPS at €1.04, up 99.8% year-over-year.
Free cash flow declined to -€183.5 million, mainly due to increased working capital.
Outlook and guidance
Market conditions are expected to remain challenging due to soft demand and high uncertainty, particularly regarding U.S. tariffs.
Management is focused on cost, technology, and innovation leadership, with efficiency and optimization programs providing stability.
Sale of TANN Group anticipated to complete in H1 2025.
Latest events from Mayr-Melnhof Karton
- Stable adjusted EBITDA and strong Pharma & Healthcare Packaging growth offset market headwinds.MMK
H1 2026 - Fit-For-Future programme drove resilient earnings and margin stability despite market softness.MMK
H1 2026 (Q&A) - Efficiency gains and transformation drive profit growth and resilience amid market challenges.MMK
Austrian Select Conference - Adjusted operating profit up 2.8%, sales down 4.8%, dividend up 11%, and cost savings delivered.MMK
H2 2025 - Adjusted operating profit up 15% like-for-like, with €250M+ in savings targeted by 2027.MMK
H2 2025 (Q&A) - Profit surged on TANN divestment and cost programs, but sales fell and free cash flow was negative.MMK
Q3 2025 - Profits fell as lower prices and higher costs offset volume gains; recovery expected in 2025.MMK
Q3 2024 - Profitability and cash flow improved, but margins declined amid weak demand and lower prices.MMK
H1 2024 - EPS up, net debt down, but sales and margins fell amid weak demand and overcapacity.MMK
H2 2024